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Abstract
Understanding how cell fate decisions are regulated is a funda-
mental goal of developmental and stem cell biology. Most studies
on the control of cell fate decisions address the contributions of
changes in transcriptional programming, epigenetic modifications,
and biochemical differentiation cues. However, recent studies have
found that other aspects of cell biology also make important
contributions to regulating cell fate decisions. These cues can have
a permissive or instructive role and are integrated into the larger
network of signaling, functioning both upstream and downstream
of developmental signaling pathways. Here, we summarize recent
insights into how cell fate decisions are influenced by four aspects
of cell biology: metabolism, reactive oxygen species (ROS), intracel-
lular pH (pHi), and cell morphology. For each topic, we discuss how
these cell biological cues interact with each other and with
protein-based mechanisms for changing gene transcription. In
addition, we highlight several questions that remain unanswered
in these exciting and relatively new areas of the field.
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Introduction
Cell fate decisions are tightly regulated by many layers of control. A
change in cell fate is ultimately defined by the acquisition of new
characteristics that come about largely through changes in transcrip-
tion. Protein-based signal transduction cascades leading to changes
in transcription factor activity are the most direct causes of tran-
scriptional changes and are among the most well-studied aspects of
the cell fate decision process. In contrast, much less is known about
how other aspects of cell biology such as changes in metabolite
concentration or mechanical forces contribute to cell fate decisions.
This is due in part to the difficulty of studying cues that are not
directly encoded in the genome. However, technological advances,
including the generation of new biosensors that can be used for live
cell imaging, improvements in quantitative fluorescence micro-
scopy, and the development of more sensitive biochemical methods
for detecting small molecules are making it easier to identify previ-
ously unrecognized control mechanisms. In this review, we discuss
recent advances in understanding the role of metabolism, reactive
oxygen species (ROS), intracellular pH (pHi), and cell morphology
and adhesions to cell fate decisions, particularly during differentia-
tion in adult, embryonic, and induced pluripotent stem cell lineages.
Metabolism
The metabolic state of a cell is the result of a complex array of
inputs, including cell signaling, availability of nutrients and oxygen,
energy needs, and biomass demands. These inputs and demands
combine to influence the rate of ATP production from glycolysis
versus oxidative phosphorylation, as well as the rate of side reac-
tions that produce anabolic intermediates. As cells differentiate, the
change in these inputs causes the metabolic state to shift. However,
the metabolic state of the cell is not merely a consequence of dif-
ferentiation. Instead, shifts in metabolism can have permissive and,
in some cases, even instructive roles in promoting differentiation
[1]. This perspective positions metabolism as a key node in the
regulation of cell fate transitions. In this section, we summarize the
metabolic programs of cells at different stages of differentiation,
briefly review some of the major cell signaling regulators of meta-
bolic state, and discuss how changes in metabolic state contribute to
cellular differentiation (Fig 1).
Changes in metabolism, often collectively referred to as “meta-
bolic reprogramming”, can shift the amount of energy and biomass
produced by glycolysis versus oxidative phosphorylation to regulate
changes in cell fate. In adult stem cell lineages, less active long-term
progenitors, such as quiescent hematopoietic stem cells (HSCs) or
satellite cells (stem cells of skeletal muscle) utilize glycolysis over
oxidative phosphorylation, whereas more actively growing and
proliferating cells are bivalent and utilize both glycolysis and oxida-
tive phosphorylation [2–5]. Embryonic stem cells (ESCs) transition
through several metabolic states during differentiation. ESCs in the
most undifferentiated, or “naive” state, have relatively high levels of
oxidative phosphorylation [6–8], although these cells still consume
high amounts of glucose and glutamine [6,9]. As ESCs differentiate
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toward the “primed” state, ATP production becomes decoupled
from oxidative phosphorylation, and the metabolic program is
shifted toward the use of glycolysis for energy and biomass produc-
tion [6,10] through a process that is regulated by the conserved
RNA-binding protein, LIN28 [7]. Energy production from oxidative
phosphorylation then increases again as differentiation proceeds
beyond the primed state. Likewise, the reprogramming of differenti-
ated somatic cells into induced pluripotent stem cells (iPSCs)
requires a shift from a bivalent metabolic program of glycolysis and
oxidative phosphorylation toward a primarily glycolytic state that
resembles the metabolism of primed ESCs [11,12]. Recent evidence
indicates that this metabolic shift occurs prior to changes in gene
expression, suggesting that it is a prerequisite for reprogramming
rather than a consequence of the cell fate change [13].
Nonetheless, in most cases, metabolic changes are initiated by
cell signaling molecules, including AMPK, HIF1a, AKT, and Myc.
AMPK, which is activated by high [AMP]/[ATP] ratios that indicate
low nutrient availability and metabolic stress, increases glycolytic
energy production, activates FOXO proteins to promote the expres-
sion of antioxidants and autophagy genes, and restricts growth by
inhibiting mTor [14,15]. This stress response program is important
for maintaining cellular homeostasis in general, and thus functions
during both self-renewal and differentiation. HIF1a is an oxygen
sensor that is stabilized by low oxygen levels and promotes a steady
state level of energy production during periods of relatively low
activity in quiescent and slowly dividing adult stem cells, such as
HSCs [2], mesenchymal stem cells (MSCs) [16], and satellite cells
[17]. HIF1a shifts the metabolic program toward glycolysis over
oxidative phosphorylation, which is conducive to the hypoxic envi-
ronments of stem cell niches that maintain quiescent stem cells, and
also minimizes the damage caused by ROS produced from mito-
chondrial respiration. In contrast, Akt and Myc promote an increase
in energy production from oxidative phosphorylation and a switch
in the utilization of glycolysis from a source of energy production to
a source of anabolic intermediates. Akt activates mTor by inhibiting
the Tsc complex, and several studies have found that this pathway
promotes differentiation of adult stem cells including HSCs, NSCs,
and ISCs [18–20]. Akt signaling also increases ROS levels by
inhibiting FOXO proteins, which has the effect of further promoting
differentiation in some types of stem cells (see next section). Myc is
also required for differentiation in the HSC and epidermal stem cell
lineages [21,22]. In addition, Myc is an important factor for repro-
gramming into iPSCs, and inhibition of mTor or induced expression
of metabolic enzymes can substitute for Myc in iPSC reprogramming
[23,24]. Thus, shifts in metabolic state are a prerequisite for dif-
ferentiation in cases where the shift is needed in order to meet the
energetic and anabolic demands of the new cell state.
Metabolic state can also influence cell fate decisions by affecting
the availability of metabolites that are important for the epigenetic
regulation of gene expression [24]. Epigenetic regulation occurs
primarily through the modification of histones and DNA, and
histone acetylation and deacetylation as well as histone and DNA
methylation and demethylation all can be regulated by metabolites.
Histone acetyltransferases (HATs) use acetyl-CoA, which is a key
metabolic intermediate between glycolysis and the TCA cycle, as a
substrate for histone acetylation. In the absence of sufficient acetyl-
CoA, global histone acetylation is reduced, and thus, the regulation
of gene expression is impaired. This connection was clearly demon-
strated in a study of in mouse adipocytes [25]. The authors found
that knockdown of ATP-citrate lyase, which generates acetyl-CoA
from citrate, caused a decrease in histone acetylation and prevented
the upregulation of genes such as glucose transporters that are
required for differentiation. Likewise, deacetylation is also sensitive
to acetyl-CoA concentrations in the cell. For example, the addition
of acetate (which increases acetyl-CoA levels) to the culture media
of human or mouse ESCs blocked histone deacetylation and delayed
differentiation, whereas inhibition of glycolysis (which decreases
acetyl-CoA levels) accelerated differentiation [26]. The effect of
glycolysis inhibition could be reversed with the addition of acetate
to the media, and pharmacological inhibition of the enzyme that
produces acetyl-CoA for histone acetylation produced a similar
phenotype, but the effect on histone deacetylation was not tested
directly. Deacetylation by sirtuins is also responsive to metabolic
inputs [27]. Sirtuins are deacetylases with a broad range of targets
including histones and transcription factors. These enzymes are
considered metabolic sensors because they use NAD+ as a cofactor
and thus become more active when [NAD+]/[NADH] ratios are
high. In addition, sirtuins both regulate and are regulated by AMPK
[28]. Sirtuin 1 (SIRT1) has been well studied during mammalian cell
differentiation and may function through different mechanisms to
both repress differentiation in some contexts and promote differenti-
ation in others. For example, SIRT1 is highly expressed in ESCs,
iPSCs, and early morula stage embryos, where it promotes pluripo-
tency and is downregulated upon differentiation [29,30]. In contrast,
genetic and pharmacological studies indicate that SIRT1 promotes
differentiation in hematopoietic and neural lineages [31,32].
The epigenetic regulators that catalyze the addition of methyl
groups, DNA methyltransferases (DNMTs) and histone methyltrans-
ferases (HMTs), use S-adenosyl methionine (SAM) as a substrate.
The rates of histone methylation are different at active versus inac-
tive promoters, and the concentration of intracellular SAM can
directly influence these rates. SAM concentrations are relatively
high in human and mouse ESCs and iPSCs, and SAM is required for
histone methylation to maintain the pluripotent state in these cell
types [33–35]. In adult tissues, there is a well-established role for
SAM in the regulation of DNA and histone methylation during
Glossary
ECM extracellular matrix
ESCs embryonic stem cells
HSCs hematopoietic stem cells
iPSCs induced pluripotent stem cells
Metabolic reprogramming Changes in metabolism that accompany
and can sometimes be necessary or
instructive for changes in cell fate
MSCs mesenchymal stem cells
Niche A specialized microenvironment in the
tissue that maintains cells in the stem
cell state
NSCs neural stem cells
pH sensor Selective proteins with post-translational
modification by protonation/
deprotonation regulating activity or
ligand binding.
ROS reactive oxygen species
SAM S-adenosyl methionine
Satellite cells Stem cells of the skeletal muscle
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oncogenesis [36], and though less is known about the role of SAM
in adult stem cell differentiation, many adult progenitors, including
HSCs [37], ISCs [38], and epidermal progenitors [39] require
DNMTs and HMTs [40]. Thus, changes in the concentration of SAM
influence cell fate transitions in many different cell types.
Likewise, enzymes that catalyze the removal of methyl groups
from histones and DNA are sensitive to the availability of specific
metabolites. For example, the Jumanji C family of histone demethy-
lases and the TET-family enzymes, which catalyze the first step of
DNA demethylation, require both the TCA cycle intermediate a-
ketoglutarate (a-KG) and the reduced (Fe2+) form of iron [41,42].
Iron is more commonly in the Fe3+ form but can be reduced to Fe2+
by vitamin C, and several recent studies revealed the importance of
vitamin C for promoting the activity of Jumonji C or TET-family
enzymes in ESCs [43–46], adult stem cells [47,48], and during iPSC
reprogramming [43,49]. Another important histone demethylase,
lysine-specific demethylase 1 (Lsd1), is also sensitive to metabolic
changes as it relies on FAD as a cofactor [50]. LSD1 is required in
mouse ESCs (mESCs) to silence self-renewal genes during differenti-
ation [51], and the homologous gene, Su(var)3-3, is also required in
the somatic cells of the Drosophila ovary to promote germ cell dif-
ferentiation [52,53]. Collectively, these findings demonstrate that
metabolic processes can influence epigenetic regulation of gene
expression at multiple levels.
In addition to the permissive roles for metabolism in cellular dif-
ferentiation described above, metabolic cues can also be instructive,
causing changes in cell signaling and gene expression sufficient to
drive the change in cell fate. For example, in satellite cells, increased
glycolysis during exit from quiescence causes a decrease in NAD+,
which reduces SIRT activity and thus increases H4K16 acetylation,
ultimately leading to the expression of key differentiation genes,
such as MyoD [54]. Another interesting example comes from a
recent study that found that intestinal stem cells (ISCs) utilize
lactate provided by the neighboring Paneth cells to sustain a high
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Figure 1. The connections between metabolism and cell fate decisions.
Metabolic inputs regulate epigenetics and cell signaling to promote changes in cell fate. Glycolysis produces metabolic intermediates that feed into the folate and one carbon
metabolism cycle to produce S-adenosylmethionine (SAM), which is a cofactor for DNA methyltransferases (DNMTs) and histone methyltransferases (HMTs). The energy
released from glycolysis and oxidative phosphorylation also converts AMP to ATP and NAD+ to NADH. AMP stimulates AMPK activity, and NAD+ is a cofactor for sirtuins, so
increased energy production decreases the activity of these enzymes. Glucose-derived acetyl-CoA enters the tricarboxylic acid (TCA) cycle to form citrate, which can be
converted back to acetyl-CoA by ATP-citrate lyase. This source of acetyl-CoA (but not acetyl-CoA derived from fatty acid oxidation) contributes to the pool of nuclear acetyl-
CoA that is essential for histone acetylation by histone acetyltransferases (HATs). a-ketoglutarate (a-KG), which is produced in the TCA cycle and in the cytoplasm, is an
essential cofactor for TET and Jumonji C enzymes, which demethylate DNA and histones, respectively. The energy released from oxidative phosphorylation converts FAD to
FADH2, and FAD is a cofactor for lysine-specific demethylase 1 (LSD1), so a reduction in FAD levels inhibits LSD1 activity. Increased oxidative phosphorylation also generates
reactive oxygen species (ROS), which promote oxidation, carbonylation, and hydroxylation as well as increase the levels of JNK and p38/MAPK pathway activity. Low levels of
oxygen (O2), for example in the HSC and satellite cell niches, increase the activity of the hypoxia inducible factor-1 (HIF-1), which promotes glycolysis.
ª 2017 The Authors EMBO reports
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level of oxidative phosphorylation [55]. Increased oxidative phos-
phorylation in ISCs causes an increase in reactive oxygen species
(ROS), which activates the p38-MAPK pathway (as discussed in the
following section). Paneth cells are part of the ISC niche, so this
suggests that metabolic cues can function as niche signals. Addi-
tional examples in which metabolic changes feed into signaling
networks to instruct cell fate decisions involve mTOR, which is a
master regulator of cell growth and proliferation. Several studies
have demonstrated that mTOR is essential for the maintenance of
pluripotency and the repression of differentiation genes in ESCs
grown under standard conditions [56]. In addition, a more recent
study found that partial inhibition of mTOR in mESCs induces the
cells to adopt a “paused” state resembling embryonic diapause [57].
The mechanism of this effect is not fully understood, but the authors
speculate that the paused state is induced by the combined effects of
mTOR inhibition on transcription, translation, and metabolism.
Lastly, in quiescent HSCs, activation of mTOR induces mitochon-
drial biogenesis, which activates proliferation and induces differenti-
ation [58].
Two recent studies demonstrated that changes in pyruvate meta-
bolism can contribute to the regulation of proliferation and differen-
tiation in epidermal and intestinal cell lineages [59,60]. Pyruvate is
the end product of glycolysis and can either enter be converted to
lactate in the cytoplasm, or be transported into the mitochondria,
where it is converted to acetyl-CoA and oxidized in the TCA cycle.
These studies provide evidence that hair follicle and intestinal stem
cells are more glycolytic than their non-stem cell progeny, and
suggest that increased conversion of pyruvate to lactate drives stem
cell proliferation whereas increased mitochondrial oxidation of
pyruvate promotes differentiation. The downstream mechanism was
not investigated, but both studies provide evidence suggesting that
high levels of Myc in the stem cells may promote the shift toward
lactate production. Interestingly, a separate study of intestinal dif-
ferentiation in zebrafish found that Wnt signaling also regulates
pyruvate metabolism [61]. Wnt signaling is generally high in epithe-
lial stem cells [62] and promotes Myc expression [63,64], suggesting
a model in which Wnt signaling, Myc, and pyruvate metabolism
function together to promote epithelial stem cell identity.
Taken together, these studies demonstrate that changes in meta-
bolism influence cell fate decisions in a variety of ways. In many
cases, the link between the metabolic cue and the cell fate decision
is reactive oxygen species as described in the next section.
Reactive oxygen species
Metabolic pathways can influence stem cell fate decisions through
the activity of ROS (Fig 1). ROS, such as superoxide anion (O2
),
hydrogen peroxide (H2O2), and hydroxyl radicals (OH
), are formed
by the reduction of molecular oxygen (O2). The toxic effects of these
ROS have been studied extensively in the context of cell prolifera-
tion, DNA damage, and apoptosis. Additionally, ROS play a crucial
role in regulating cellular processes like oxidative stress responses,
aging, and stem cell fate decisions. In this section, we review recent
advances in the understanding of the role of ROS in cell differentia-
tion. ROS are commonly generated as by-products of metabolic reac-
tions occurring in the mitochondria, mainly in the electron transport
chain. ROS levels are controlled by several proteins, such as NADPH
oxidases, which have activity that results in formation of superox-
ides, superoxide dismutases (SOD), which reduce O2
 to H2O2, and
other enzymes, including thioredoxins, glutathione peroxidases, and
peroxiredoxins [65,66].
Recent studies identified examples in which specific ROS regula-
tors are necessary for stem cell differentiation. For example, Kim
et al [67] found that peroxiredoxins, PrxI and Prx II, promote mouse
embryonic stem cell differentiation into neurons by regulating ROS
levels. In addition, Hochmuth et al [68] found that Nrf2, which
controls transcription of antioxidant enzymes like thioredoxins and
peroxidases, and Keap1, a negative regulator of Nrf2, regulate
Drosophila intestinal stem cell proliferation by altering intracellular
ROS. Other studies have focused on the downstream effects of
changes to ROS levels, and in general, these studies find that
increased ROS levels are associated with differentiation. During
Drosophila testes germline stem cell (GSC) differentiation, GSCs
maintain reduced levels of ROS, regulated by Keap1 and Nrf2 [69].
An increase in ROS in GSCs caused a decrease in the number of
GSCs and promoted differentiation. In mammalian HSCs, an eleva-
tion in ROS levels occurs during differentiation into common
myeloid progenitors [70]. Likewise, quiescent multipotent
hematopoietic progenitor cells in the Drosophila lymph gland have
elevated levels of ROS, which promotes differentiation [71]. In these
studies, scavenging ROS by expressing antioxidant proteins like
catalase in vivo or by the addition of N-acetylcysteine, delayed dif-
ferentiation, whereas increasing ROS by adding paraquat or mutat-
ing mitochondrial complex I proteins like ND75, promoted
differentiation [69,71,72]. During vascular smooth muscle cell dif-
ferentiation, inhibition of ROS activity decreased the cellular expres-
sion of differentiation proteins, whereas an elevation in ROS activity
increased expression of these differentiation markers [73]. In
contrast to this trend, two studies show that elevated ROS levels
promote self-renewing, proliferative neural and mouse spermatogo-
nial stem cell fate [74,75]. Additionally, elevated ROS levels
promote Drosophila intestinal stem cell proliferation [68].
Reactive oxygen species instruct stem cell fate decisions by regu-
lating key signal transduction pathways. A mechanism by which
ROS control signaling pathways that affect stem cell differentiation
is by affecting post-translational modifications of regulatory
proteins, such as phosphatases. For example, ROS have been shown
to mediate cysteine and methionine oxidation, protein carbonyla-
tion, and hydroxylation (reviewed by [66]). Another mechanism by
which ROS influences differentiation decisions is by directly
affecting the activity of transcription factors and essential signaling
pathway proteins responsible for activating genetic differentiation
programs. The most commonly studied signaling pathways in this
regard are the JNK and p38 MAPK pathways and an increase in ROS
typically activates these pathways to promote differentiation [68,71–
73]. For example, in Drosophila hematopoietic progenitor cells,
elevated ROS levels stimulate the JNK pathway to promote differen-
tiation by activating transcription factor FoxO and the derepression
of polycomb activity [71]. However, FoxO also increases antioxidant
activity, which reduces ROS levels and thus creates a negative feed-
back loop that eventually brings FoxO activity back down. Likewise,
in mammalian hematopoietic stem cells (HSCs), low levels of ROS
are necessary for HSC self-renewal whereas elevated levels of ROS
promote differentiation by stimulating the activity of p38 and mTOR
signaling pathways [76]. During vascular smooth muscle
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differentiation and mouse spermatogonial stem cell self-renewal,
increased ROS levels activate p38 MAPK signaling pathway, which
promotes the transcription of serum response factor (SRF), and ulti-
mately increases the activity of differentiation proteins, such as a-
actin and calponin [73]. Additionally, high levels of ROS in Droso-
phila GSCs promote differentiation by increasing the transcription of
the epidermal growth factor receptor ligand, Spitz, thereby activat-
ing the MAPK signaling pathway [69]. Collectively, these studies
demonstrate that ROS concentrations are tightly controlled during
cellular differentiation and that changes in ROS concentrations play
important roles in the cell fate decision process.
Intracellular pH
A long-held view is that pHi is constitutively maintained between
7.2 and 7.4 in normal mammalian cells and only dysregulated from
this narrow range in diseases, including being constitutively
increased in cancer [77,78] and decreased in neurodegenerative
disorders [79,80]. However, emerging evidence indicates there are
transient increases in pHi in normal mammalian cells during cell
cycle progression [81], directional migration [82,83], and differenti-
ation [84–87]. Although the role of pHi dynamics in regulating cell
fate decisions remains understudied, we highlight recent findings on
this topic and emphasize questions that remain to be addressed
(Fig 2).
Increasing evidence suggests that changes in pHi are necessary
for embryonic stem cell differentiation. We recently showed a tran-
sient increase in pHi during differentiation of clonal naı¨ve mESCs to
primed epiblast-like cells (EpiSC), which when prevented, blocks
differentiation as indicated by attenuated expression of epiblast cell
markers, including Pax6, Brachyury, and Fgf5, as well as the miRNA
cluster mir-302 [84]. The increased pHi from ~7.40 to ~7.65 occurs
during the first 3 days of spontaneous differentiation and then
returns to pHi values seen in naı¨ve cells, which suggests that the
higher pHi is necessary for the differentiation process but not for
maintaining a differentiated state. Consistent with this prediction,
an earlier study by Edwards et al [88] found that pHi increases from
zygote to the morula stage. In a different embryonic cell model, Li
et al [87] showed that inhibiting activity of the plasma membrane
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Figure 2. Mechanisms by which pHi could regulate cell fate decisions.
pHi increases during embryonic and adult stem cell differentiation, epithelial-to-mesenchymal transitions, and carcinoma transformations. Theoretically, pH-sensitive
proteins (“pH sensors”) that undergo protonation or deprotonation upon changes in pHi could regulate cell fate decisions by affecting proton transporter activity, cellular
metabolism, and epigenetic modifications like histone deacetylation and DNAmethylation. However, in most cases, the specific mechanisms by which pHi could regulate cell
fate decisions are unknown.
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Na-H exchanger-1 (NHE1), markedly attenuates differentiation of
CGR8 clonal mESCs into cardiomyocytes resulting in a decreased
expression of the transcription factors Nkx2-5 and Tbx5 and
decreased abundance of a-myosin heavy chain. Although changes
in pHi during differentiation were not determined, inhibiting NHE1,
which is an acid extruder, is predicted to lower pHi. This group also
found that NHE1 activity potentiates differentiation of P19 embry-
onal carcinoma cells into neurons [89]. In contrast, umbilical cord-
derived human mesenchymal stem cells (MSCs) have a higher pHi
than differentiated cells. Lowering pHi of these cells by pharmaco-
logical inhibition of NHE1 promotes differentiation to an osteogenic
lineage but has no effect on differentiation to an adipogenic lineage
[90].
Recent studies, including studies from our laboratories, suggest
that differentiation occurring during Drosophila adult epithelial folli-
cle stem cell lineages requires changes in pHi. Using the genetically
encoded pHi biosensor pHluorin, we showed a lower pHi in follicle
stem cells of the adult Drosophila ovary compared with differenti-
ated daughter cells. Preventing the increased pHi by loss of Dnhe2,
the Drosophila ortholog of mammalian NHE1, inhibits differentia-
tion, impairs germarium morphology, and results in infertility [84].
Kru¨ger and Bohrmann [91] also found an anteroposterior pHi-
gradient in follicle and nurse cells of the Drosophila ovary, although
significance in oogenesis was not determined.
It remains to be determined whether the lower pHi in self-
renewing cells or the higher pHi in differentiating cells is an active
process. In endometrial epithelial cells, LeftyA inhibits NHE1 to
actively maintain a lower pHi [92]. Likewise, in mESCs, our findings
that the increased pHi with differentiation is transient and seen only
during the first 72 h are consistent with an active regulation of pHi
[84]. Because increased pHi promotes proliferation, the decrease
after 72 h may function to limit proliferation. As described below, a
constitutively higher pHi is seen in most cancers and can induce
hyperproliferation and dysplasia even in the absence of activated
oncogenes [93].
Considered more broadly, a role for pHi dynamics in differentia-
tion, epithelial plasticity, and morphogenesis remains understudied.
Increased pHi is reported to enable or be necessary for the differenti-
ation of CD4+ T helper 9 (Th9) cells [85], epithelial-to-mesen-
chymal transition (EMT) [86], and neural fates from ectoderm
during Xenopus development [94]. In contrast, expression of the Cl-
HCO3 exchanger AE2, which as an acid loader facilitating HCO3
efflux should lower pHi, is necessary for clonal mouse macrophages
to differentiate into osteoclasts [95], although a role for pHi dynam-
ics was not determined. Recent work shows that a glycolysis gradi-
ent in mouse and chick embryo tail bud generates a more acidic
extracellular pH (pHe) in the tail bud, which when experimentally
manipulated to be more alkaline, results in slower axis elongation
[96]. Additionally, decreased pHe from extracellular lactic acid
generated by lactate dehydrogenase enables myofibroblast differen-
tiation in an EMT-like fibrosis by increasing acid-induced activation
of latent TGF-b in the extracellular matrix [97], and an acidic pHe
enables differentiation of MSCs into cancer-associated fibroblasts
through a mechanism involving a pH-sensitive GPCR that regulates
Yes-associated protein (YAP) signaling [98]. In normal adult tissues,
pHe is ~7.4 and higher than pHi of ~7.2. In most cancers, this gradi-
ent is reversed, with pHe being ~7.0 or lower while pHi is ~7.6 and
higher [77,78]. An intriguing prediction that remains to be verified
is whether cancer initiating cells, analogous to stem cells, might
have a lower pHe and higher pHi than differentiated cancer cells. In
support of this prediction, an acidic pHe promotes self-renewal of
glioma stem cells by increasing stability of hypoxia inducible factor
2a [99].
The mechanisms by which pH dynamics regulates differentia-
tion remain largely unknown. However, based on our previous
findings on pHi-dependent cell behaviors such as proliferation
and migration, we speculate important roles for pH sensors,
defined as selective proteins with post-translational modification
by protonation/deprotonation regulating activity or ligand binding
[100]. Our findings with pHi-regulated Drosophila follicle stem cell
differentiation suggest pH sensing by the hedgehog signaling
pathway [84]. Previous findings in Drosophila eye epithelium
indicate pHi-dependent Wnt signaling with a higher pHi enabling
binding of disheveled to the plasma membrane and being neces-
sary for planar cell polarity [101]. With regard to pH-dependent
post-translational modification, a decreased pHi is associated with
global histone deacetylation [102]. Epigenetic modifications such
as histone modification and DNA methylation have established
roles in cell differentiation by changing chromatin structure to
activate or inhibit gene expression. Although unique for each
stem cell lineage, in general, DNA silencing by methylation of
CpG islands suppresses the expression of genes involved in cell
cycle exit and terminal differentiation and hence preserves the
progenitor self-renewing state [103].
Metabolic reprogramming is another potential mechanism for
pHi-regulated epigenetic modifications [104]. Recent findings show
that a more acidic pHi promotes promiscuous enzymatic activity
of lactate dehydrogenase to convert a-ketoglutarate to the L
enantiomer of 2-hydroxyglutarate, compared with conventional
lactate dehydrogenase conversion of pyruvate to lactate [105,106].
L- and D-2-hydroxyglutarate antagonize a-ketoglutarate-regulated
chromatin modifications associated with differentiation and also
stabilize expression of HIF-1a [85,86]. Additionally, stabilized HIF-
1a promotes reprogramming to a glycolytic metabolism during the
ESC to EpiSC transition [6]. Hence, increased pHi during stem cell
differentiation could enable reprogramming to a more glycolytic
phenotype, which could be mediated by glycolytic enzymes that are
pH sensors with increased activity at higher pH, such as phospho-
fructokinase-1 [77,78]. While studies have begun to uncover the
integral role of pH dynamics in regulating cell fate changes, an
important future direction is to identify the mechanisms mediating
this effect.
Cell morphology and adhesion dynamics
Although differentiation often includes changes in cell shape and
cell adhesion, including both cell–cell and cell-matrix adhesion, we
have an incomplete understanding of how these changes are regu-
lated during differentiation and contribute to the differentiation
process. Understanding the underlying cell biology of differentia-
tion, especially during in vivo development, requires knowledge of
how the cell interprets its niche through cell shape and adhesion-
derived mechanical forces. In this section, we review recent
progress in how cell morphology and mechanical cues instruct cell
fate decisions (Fig 3).
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Cell-substrate adhesion
Extracellular matrix (ECM) interactions with integrins and the
changes in cell shape and tensional forces they generate provide
instructive cues in stem cell fate decisions for both embryonic and
adult stem cells, although downstream pathways result in divergent
outcomes depending on the cellular context. Variable matrix elastic-
ity directs MSC lineage specification with a greater selectivity than
through biochemical cues and generates cellular fate memory that
persists after cells are removed from a given matrix [107]. Further-
more, pre-committing naive MSCs on a matrix stiffness that most
closely recapitulates in vivo niche stiffness improves microenviron-
ment adaptation upon implantation [107]. The effect of cell shape
on MSC fate decisions has also been shown by plating cells on small
fibronectin islands, which reveals that cells with a rounded
morphology differentiate to adipogenic lineages, while cells with a
flattened cell shape differentiate to osteogenic lineages [108]. This
morphology-driven differentiation is dependent on activity of the
low molecular weight GTPase RhoA, indicating that the mechanical
cues of cell shape and contractility contribute to lineage
commitment in MSCs. In support of this finding, McBeath and
colleagues [108] suggest that changes in cell shape sensed through
integrin binding of ECM ligands, which provide tensional forces,
can drive signaling cascades that result in altered gene expression in
MSCs.
In contrast to these MSCs that respond to integrin signaling with
self-renewal, ECM–integrin interactions facilitate differentiation in
mouse ESCs [109]. Teasing apart the roles of mechanical forces
resulting from integrin-mediated cell–ECM adhesion versus E-
cadherin-mediated cell–cell adhesion, Uda et al [110] found that
force via integrins but not E-cadherins decreases Oct3/4 expression
in mouse ESCs, suggesting mechanical forces from distinct force
transduction pathways can play divergent roles in embryonic stem
cell biology.
Divergent roles for cadherin-mediated and integrin-mediated
force transduction pathways may occur in the stem cell niches
present in Drosophila melanogaster gonad development. DE-
cadherin, the Drosophila melanogaster homolog of E-cadherin,
mediates cell–cell adhesion between germline stem cells and other
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Figure 3. Mechanical and morphological cues regulate cell fate decisions through distinct signaling mechanisms.
Cues provided by extracellular matrix (ECM) ligands, ECM stiffness, cell shape, cell-substrate adhesion, cell–cell adhesion, and cytoskeleton architectures inform the cell of
its surrounding niche (right panel). The naïve state of clonal embryonic stem cells is routinely maintained in medium supplemented with leukemia inhibitory factor (LIF),
which activates STAT3 to induce expression of naïve pluripotent target genes. However, expression of E-cadherin in pluripotent stem cells is sufficient to promote
LIF-independent self-renewal by activating STAT3 to induce expression of naïve pluripotent target genes. This later effect requires the b-catenin-binding region of E-cadherin
(left panel). With increased actin polymerization, myocardin-related transcription factor (MRTF), which is retained in the cytoplasm by binding to G-actin, translocates
to the nucleus where it binds the transcription factor serum response factor (SRF) to activate genes regulating differentiation programs (middle panel). In response to
integrin-mediated cell-substrate adhesion, the lowmolecular weight GTPase Rho activates Rho-associated protein kinase (ROCK) to generate actomyosin contractility, which
results in nuclear translocation of yes-associated protein (YAP) (right panel).
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cells within the Drosophila ovary niche for both proper recruitment
and anchoring [111]. Somatic stem cells within the Drosophila ovary
generate follicle progenitor cells and several differentiated cells
within the chamber. These epithelial stem cells are similarly
anchored to the surrounding niche by DE-cadherin in order to
prevent differentiation [112]. In addition to this cadherin-mediated
cell–cell adhesion, integrins also enable follicle stem cells in the
Drosophila ovary to adhere to surrounding basal lamina in the
niche, anchoring them in position to respond to cues regulating their
differentiation [113]. During gonad morphogenesis in the Drosophila
testis, germline stem cells contact hub cells in the niche. Integrin-
dependent adhesion but not DE-cadherin-dependent adhesion posi-
tions the hub cells such that ECM surrounding the gonads anchors
the niche and the germline stem cells [114,115]. Somatic stem cells
within the Drosophila testis must also contact hub cells to maintain
self-renewal and proliferation, but these contacts are DE-cadherin-
mediated [115]. Though dependent on distinct anchoring mecha-
nisms, positioning of both germline stem cells and somatic stem
cells along hub cells within the Drosophila testis allows cooperation
during gametogenesis as both cell types respond in different ways to
local JAK-STAT signaling within the niche [116]. A recent study
suggests that DE-cadherin affects signaling in the Drosophila ISCs
through a feedback loop that couples enterocyte cell death to ISC
divisions [117]. In this tissue, b-catenin is typically sequestered at
the adherens junctions in enterocytes, but enterocyte cell death
disrupts these junctions and thus causes the release of b-catenin. b-
catenin then translocates to the nucleus where it activates the
expression of rhomboid, which promotes the secretion of EGF
ligands and ultimately leads to increased ISC proliferation.
We highlight here merely some advances in our understanding
of how cell–ECM interactions and cell shape contribute to stem cell
fate decisions. For more comprehensive discussions, we refer read-
ers to reviews on ECM, integrins, and growth factors directing stem
cell fate [118], nanoscale features of integrin–matrix interactions,
matrix stiffness and 2D versus 3D cultures [119], and integrin- and
cadherin-mediated adhesion in maintaining a supportive niche for
stem cell anchoring, self-renewal, and differentiation [120–122].
Cell–cell adhesion
The role of cadherin-mediated cell–cell adhesion in pluripotent cells
is currently an area of active investigation. In mouse embryos, the
adherens junction protein E-cadherin is highly expressed until
gastrulation, when E-cadherin is downregulated as epithelial
epiblasts undergo an epithelial-to-mesenchymal transition (EMT)
and germ layers are specified. Animals null for E-cadherin are
unable to complete embryogenesis beyond this point [123,124],
which may be due in part to the lack of mechanical forces at adhe-
rens junctions [125]. However, heterozygous loss of E-cadherin
combined with N-cadherin knock-in results in normal embryonic
development [126]. Whether the in vivo role for E-cadherin is simi-
lar for differentiation of embryonic stem cells in vitro remains
controversial. Spencer et al [127] found that mouse ESC differentia-
tion involves traditional markers of EMT such as an E-cadherin to
N-cadherin switching, increased expression of the E-cadherin
repressors Snail and Slug, and increased cell motility. Also in
support of a pluripotent self-renewal promoting role for cell–cell
adhesion, E-cadherin-mediated cell–cell contacts promote mouse
ESC self-renewal and induced pluripotent stem cell (iPSC)
generation [128,129]. In agreement with this proposed role, mouse
ESCs null for E-cadherin have a transcriptional profile that more
closely resembles differentiated epiblast stem cells than self-
renewing naı¨ve ESCs [130]. Interestingly, genes most differentially
expressed in self-renewing ESCs from E-cadherin/ compared with
WT mice are not limited to cell adhesion and motility but also
includes transcripts related to metabolic processes, catabolism, and
apoptosis [130]. A comprehensive evaluation of the roles for E-
cadherin in embryonic stem cells, pluripotency, and self-renewal is
beyond the scope of our discussion of lesser-studied regulators of
stem cell biology, but we refer the reader to several excellent
reviews on this topic [131–133].
Like E-cadherin, the role of b-catenin in stem cell self-renewal
and differentiation is currently controversial, despite consensus on
the importance of repressive transcriptional activity Tcf3 down-
stream of canonical Wnt signaling, as described more completely
in recent reviews on embryonic [134] and adult [135] stem cells.
For embryonic stem cells, conflicting findings may result from
distinct b-catenin functions as an adherens junction protein and a
signaling molecule in the Wnt pathway, with perhaps a cell–cell
adhesion function being more critical. In brief, for embryonic stem
cells, one view is that b-catenin is not necessary for the self-
renewal and expansion of naı¨ve mESCs, but its absence eliminates
the self-renewal response to Gsk3 inhibition [136]. Another non-
contradictory view is that a complex of b-catenin, E-cadherin and
Oct 4 but not b-catenin transcriptional activity is necessary for
pluripotency [137]. Additionally, b-catenin may be necessary for
subsequent differentiation stages because mesendodermal germ
layer formation and neuronal differentiation are defective in
b-catenin-null mESCs [138]. Redundancy between catenins may
also explain conflicting findings because in b-catenin-null mESCs,
loss of c-catenin promotes exit from pluripotency [139], which
further suggests the importance of the adherens junctions but not
signaling function of b-catenin in embryonic stem cell self-renewal
and differentiation.
Actin filaments
Although actin filament dynamics regulate cell-substrate adhesion,
cell–cell adhesion, and cell morphology, we have limited under-
standing of its direct role in stem cell differentiation and lineage
specification. Moreover, how actin cytoskeleton dynamics might
regulate transcriptional programs in cell differentiation is incom-
pletely understood, although current evidence implicates roles for
YAP, transcriptional activator with PDZ-binding motif (TAZ), and
myocardin-related transcription factor (MRTF), which are transcrip-
tional regulators responding to mechanical force or actin remodel-
ing. YAP and TAZ, transcriptional cofactors in the Hippo signaling
pathway, are both required for early mouse embryo development
[140]. In response to mechanical cues, YAP and TAZ translocate
from the cytoplasm to the nucleus where they bind the transcription
factor TEAD and other promoter-specific transcription factors (re-
viewed in [141]). Higher stiffness of the surrounding extracellular
matrix results in nuclear YAP/TAZ localization by an unclear mech-
anism that senses cell tension [142]. Multiple types of mouse stem
and progenitor cells, including ESCs, are characterized by upregu-
lated YAP expression, suggesting that Hippo signaling promotes
pluripotency-related pathways [143]. Additionally, Yorkie, the
Drosophila homolog of Yap, causes increased ISC proliferation in
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response to intestinal epithelia damage [144,145] and also functions
downstream of hedgehog signaling to promote proliferation of folli-
cle stem cells [146]. In the mouse intestine, Yap activity contributes
to the downregulation Wnt signaling, which is the key ISC self-
renewal signal, and overexpression of Yap causes ISC loss whereas
knockout of Yap causes an increase in the number of ISCs and
Paneth cells. In contrast, overexpression of Yap in the epidermis has
the opposite effect, causing an expansion of the stem cell pool and
the formation of squamous cell-like carcinomas. However, knockout
of the upstream negative regulator, Mst1/2, does not have the same
effect, suggesting that Yap is activated by a non-canonical mecha-
nism in this tissue.
Myocardin-related transcription factor is another link between
actin remodeling and transcriptional regulation. In contrast to
nuclear translocation of YAP/TAZ in response to cell-substrate
signals, MRTF is translocated from the cytosol to the nucleus in
response to increased actin polymerization [147,148]. In the
nucleus, MRTF is a cofactor for transcriptional regulation by SRF to
induce expression of over 200 transcripts, mostly related to actin
dynamics, cell motility, muscle-specific genes, and miRNAs (re-
viewed in [149]). Although a role for MRTF in ESCs remains unde-
termined, it is important for adult MSC differentiation. Specifically,
the degree of cell spreading in a precursor of the adipogenic and
osteogenic lineages increases actin polymerization, and MRTF is
translocated to the nucleus to promote osteogenic gene expression
programs [150–154].
Despite recent advances, further understanding of how cell
shape, adhesion, and actin filament dynamics contribute to stem cell
differentiation is needed to inform how directed in vitro differentia-
tion protocols are optimized for regenerative medicine applications.
For example, Gilbert et al [155] showed that differentiating muscle
cells reorganizes their actin cytoskeleton to match their cultured
substrate stiffness, significantly improving the cell’s ability to
engraft and properly heal after implantation when the cultured
substrate stiffness matched that of the in vivo niche. Additionally,
Myers et al [156] found that cell colony geometry is a driver of stem
cell fate decisions in 2D culture systems: patterning of colonies
according to uniform size, density, and shape resulted in improved
homogeneity and yield of human iPSC-derived cardiomyocytes.
Zoldan et al [125] found that culturing hESCs on variable scaffold
stiffnesses was sufficient to induce lineage-specific gene expression.
As the field of regenerative medicine continues to develop in vitro-
derived cell replacement therapeutics, knowledge of the underlying
cell biology of stem cell shape and adhesion as it pertains to both
in vivo development and in vitro differentiation will greatly inform
future studies.
Conclusion
Our review highlights the diversity of mechanisms used to regulate
cell fate decisions. Assuming that a more robust cell fate determina-
tion process provides an evolutionary advantage, it seems likely that
different cells are regulated by multiple and sometimes distinct cues.
Extracellular chemical and mechanical cues integrate with intracel-
lular protein- and metabolite-based signaling for the complex
control of cell fate decisions (Fig 4). Changes in metabolic state
directly impact protein-based regulation of cell fate decisions by, for
example, shifting the availability of metabolites that are required for
epigenetic modifications and regulating metabolic sensors, such as
AMPK and sirtuins [24]. Metabolic changes are also the primary
causes of changes in ROS concentrations, which contribute to cell
fate decisions through the JNK and p38 MAPK pathways [66].
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Figure 4. Network of cell biological cues that instruct cell fate decisions.
Examples of cell fate decisions include naïve embryonic stem cells (ESC)
undergoing self-renewal (curved arrow) or differentiating into a primed ESC
(straight arrow); adult stem cells self-renewing (curved arrow) or becoming
differentiated cells (straight arrow); and reprogramming of differentiated cells to
form induced pluripotent stem cells (iPSCs). Cell fate decisions are directly
influenced by cell biological cues like metabolism, intracellular pH (pHi), reactive
oxygen species (ROS), and cell morphology (short colored arrows). Additionally,
since these cell biological cues can affect each other (long colored arrows), these
cues also affect cell fate decisions indirectly. Metabolism can affect pHi, ROS and
cell morphological changes. pHi and ROS can influence cellular metabolism and
morphology. Cell morphological changes can also affect metabolic changes.
Therefore, the interaction between these cell biological cues forms a network of
cues that instruct cell fate decisions.
Box 1: In need of answers
(i) What roles do metabolic pathways other than glycolysis and the
TCA cycle play in cellular differentiation?
(ii) Do changes in S-adenosyl methionine concentrations regulate
adult stem cell self-renewal and/or differentiation?
(iii) Do the ROS signals that contribute to the regulation of cellular
differentiation promote aging?
(iv) What are the key pH-sensing proteins that mediate effects of pHi
dynamics in regulating cell fate?
(v) Do changes in pHi affect cellular differentiation by influencing
metabolism, reactive oxygen species, or the cytoskeleton?
(vi) Despite considerable work, there is still a lack of a comprehensive
understanding about the role of adherens junctions in ESC
pluripotency.
(vii) How do changes in actin dynamics, cell shape, and cell adhesion
regulate cellular differentiation, particularly with regard to epige-
netic and transcriptional effects?
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Increased ROS levels feedback to regulate metabolism by activating
transcription factors such as FoxO family members that regulate
metabolism, and can promote the activity of Rho-associated protein
kinase (ROCK), which regulates cytoskeletal-associated proteins
such as myosin, talin, and cofilin [157]. Additionally, Hippo signal-
ing, which responds to mechanical cues, can induce changes in
metabolism [158], and metabolism can affect cell shape and
cytoskeletal dynamics through the effects of AMPK on cell polarity
proteins and myosin regulatory light chain [159–161]. Metabolic
changes that shift in the balance of energy and biomass production
from glycolysis versus oxidative phosphorylation also affect pHi by
changing the redox state of the cell. Changes in pHi can also feed-
back to regulate metabolism by, for example, affecting the activity
of pH-sensitive enzymes such as phosphofructokinase-1 [162,163].
Finally, changes in pHi can also impact cell shape and mechanical
cues through effects on pH-sensing actin regulatory proteins, such
as cofilin and talin [164,165].
Collectively, the studies summarized here demonstrate the exten-
sive contribution of cell biological regulators to the mechanisms that
govern cell fate decisions. Nevertheless, many open questions
remains (Box 1). However, the field is still relatively new, and the
increasing interest combined with new methods for studying the cell
biology of cell fate decisions in vivo is likely to lead to more insights
into this significant area of developmental biology.
Conflict of interest
The authors declare that they have no conflict of interest.
Acknowledgements
This work was funded by a National Institute of Health grant GM116384 to D.
L. Barber and T. G. Nystul. In addition, Francesca Aloisio is supported by the
Howard Hughes Medical Institute Gilliam Fellowship, UCSF Moritz-Heyman
Discovery Fellowship, and an NIH T32 grant GM008568.
References
1. Shyh-Chang N, Daley GQ, Cantley LC (2013) Stem cell metabolism in
tissue development and aging. Development 140: 2535 – 2547
2. Simsek T, Kocabas F, Zheng J, Deberardinis RJ, Mahmoud AI, Olson EN,
Schneider JW, Zhang CC, Sadek HA (2010) The distinct metabolic profile
of hematopoietic stem cells reflects their location in a hypoxic niche.
Cell Stem Cell 7: 380 – 390
3. Suda T, Takubo K, Semenza GL (2011) Metabolic regulation of
hematopoietic stem cells in the hypoxic niche. Cell Stem Cell 9:
298 – 310
4. Almada AE, Wagers AJ (2016) Molecular circuitry of stem cell fate in
skeletal muscle regeneration, ageing and disease. Nat Rev Mol Cell Biol
17: 267 – 279
5. Rocheteau P, Gayraud-Morel B, Siegl-Cachedenier I, Blasco MA,
Tajbakhsh S (2012) A subpopulation of adult skeletal muscle stem cells
retains all template DNA strands after cell division. Cell 148: 112 – 125
6. Zhou W, Choi M, Margineantu D, Margaretha L, Hesson J, Cavanaugh
C, Blau CA, Horwitz MS, Hockenbery D, Ware C et al (2012) HIF1a
induced switch from bivalent to exclusively glycolytic metabolism
during ESC-to-EpiSC/hESC transition. EMBO J 31: 2103 – 2116
7. Zhang J, Ratanasirintrawoot S, Chandrasekaran S, Wu Z, Ficarro SB, Yu
C, Ross CA, Cacchiarelli D, Xia Q, Seligson M et al (2016) LIN28
regulates stem cell metabolism and conversion to primed pluripotency.
Cell Stem Cell 19: 66 – 80
8. Takashima Y, Guo G, Loos R, Nichols J, Ficz G, Krueger F, Oxley D,
Santos F, Clarke J, Mansfield W et al (2014) Resetting transcription
factor control circuitry toward ground-state pluripotency in human.
Cell 158: 1254 – 1269
9. Carey BW, Finley LWS, Cross JR, Allis CD, Thompson CB (2015) Intracel-
lular a-ketoglutarate maintains the pluripotency of embryonic stem
cells. Nature 518: 413 – 416
10. Zhang J, Khvorostov I, Hong JS, Oktay Y, Vergnes L, Nuebel E, Wahjudi
PN, Setoguchi K, Wang G, Do A et al (2011) UCP2 regulates energy
metabolism and differentiation potential of human pluripotent stem
cells. EMBO J 30: 4860 – 4873
11. Folmes CDL, Dzeja PP, Nelson TJ, Terzic A (2012) Metabolic plasticity in
stem cell homeostasis and differentiation. Cell Stem Cell 11: 596 – 606
12. Folmes CDL, Nelson TJ, Martinez-Fernandez A, Arrell DK, Lindor JZ,
Dzeja PP, Ikeda Y, Perez-Terzic C, Terzic A (2011) Somatic oxidative
bioenergetics transitions into pluripotency-dependent glycolysis to
facilitate nuclear reprogramming. Cell Metab 14: 264 – 271
13. Hansson J, Rafiee MR, Reiland S, Polo JM, Gehring J, Okawa S, Huber W,
Hochedlinger K, Krijgsveld J (2012) Highly coordinated proteome
dynamics during reprogramming of somatic cells to pluripotency. Cell
Rep 2: 1579 – 1592
14. Mihaylova MM, Shaw RJ (2011) The AMPK signalling pathway coordi-
nates cell growth, autophagy and metabolism. Nat Cell Biol 13:
1016 – 1023
15. Ito K, Suda T (2014) Metabolic requirements for the maintenance of
self-renewing stem cells. Nat Rev Mol Cell Biol 15: 243 – 256
16. Palomäki S, Pietilä M, Laitinen S, Pesälä J, Sormunen R, Lehenkari P,
Koivunen P (2013) HIF-1a is upregulated in human mesenchymal stem
cells. Stem Cells 31: 1902 – 1909
17. Liu W, Wen Y, Bi P, Lai X, Liu XS, Liu X, Kuang S (2012) Hypoxia
promotes satellite cell self-renewal and enhances the efficiency of
myoblast transplantation. Development 139: 2857 – 2865
18. Yamazaki S, Iwama A, Takayanagi S-I, Morita Y, Eto K, Ema H,
Nakauchi H (2006) Cytokine signals modulated via lipid rafts mimic
niche signals and induce hibernation in hematopoietic stem cells.
EMBO J 25: 3515 – 3523
19. Yilmaz ÖH, Katajisto P, Lamming DW, Gültekin Y, Bauer-Rowe KE,
Sengupta S, Birsoy K, Dursun A, Yilmaz VO, Selig M et al (2012)
mTORC1 in the Paneth cell niche couples intestinal stem-cell function
to calorie intake. Nature 486: 490 – 495
20. Zhou J, Shrikhande G, Xu J, McKay RM, Burns DK, Johnson JE, Parada LF
(2011) Tsc1 mutant neural stem/progenitor cells exhibit migration defi-
cits and give rise to subependymal lesions in the lateral ventricle.
Genes Dev 25: 1595 – 1600
21. Wilson A, Murphy MJ, Oskarsson T, Kaloulis K, Bettess MD, Oser GM,
Pasche A-C, Knabenhans C, Macdonald HR, Trumpp A (2004) c-Myc
controls the balance between hematopoietic stem cell self-renewal
and differentiation. Genes Dev 18: 2747 – 2763
22. Waikel RL, Kawachi Y, Waikel PA, Wang XJ, Roop DR (2001) Deregulated
expression of c-Myc depletes epidermal stem cells. Nat Genet 28:
165 – 168
23. Cao Y, Guo W-T, Tian S, He X, Wang X-W, Liu X, Gu K-L, Ma X, Huang
D, Hu L et al (2015) miR-290/371-Mbd2-Myc circuit regulates glycolytic
metabolism to promote pluripotency. EMBO J 34: 609 – 623
24. Ryall JG, Cliff T, Dalton S, Sartorelli V (2015) Metabolic Reprogramming
of Stem Cell Epigenetics. Cell Stem Cell 17: 651 – 662
EMBO reports ª 2017 The Authors
EMBO reports The cell biology of cell fate decisions Sumitra Tatapudy et al
10
25. Wellen KE, Hatzivassiliou G, Sachdeva UM, Bui TV, Cross JR, Thompson
CB (2009) ATP-citrate lyase links cellular metabolism to histone acety-
lation. Science 324: 1076 – 1080
26. Moussaieff A, Rouleau M, Kitsberg D, Cohen M, Levy G, Barasch D,
Nemirovski A, Shen-Orr S, Laevsky I, Amit M et al (2015) Glycolysis-
mediated changes in acetyl-CoA and histone acetylation control the
early differentiation of embryonic stem cells. Cell Metab 21:
392 – 402
27. Correia M, Perestrelo T, Rodrigues AS, Ribeiro MF, Pereira SL, Sousa MI,
Ramalho-Santos J (2017) Sirtuins in metabolism, stemness and dif-
ferentiation. Biochim Biophys Acta 1861: 3444 – 3455
28. Ruderman NB, Xu XJ, Nelson L, Cacicedo JM, Saha AK, Lan F, Ido Y
(2010) AMPK and SIRT1: a long-standing partnership? Am J Physiol
Endocrinol Metab 298: E751 – E760
29. Calvanese V, Lara E, Suárez-Alvarez B, Abu Dawud R, Vázquez-Chan-
tada M, Martínez-Chantar ML, Embade N, López-Nieva P, Horrillo A,
Hmadcha A et al (2010) Sirtuin 1 regulation of developmental genes
during differentiation of stem cells. Proc Natl Acad Sci USA 107:
13736 – 13741
30. Saunders LR, Sharma AD, Tawney J, Nakagawa M, Okita K, Yamanaka S,
Willenbring H, Verdin E (2010) miRNAs regulate SIRT1 expression
during mouse embryonic stem cell differentiation and in adult mouse
tissues. Aging 2: 415 – 431
31. Hisahara S, Chiba S, Matsumoto H, Tanno M, Yagi H, Shimohama S,
Sato M, Horio Y (2008) Histone deacetylase SIRT1 modulates neuronal
differentiation by its nuclear translocation. Proc Natl Acad Sci USA 105:
15599 – 15604
32. Peled T, Shoham H, Aschengrau D, Yackoubov D, Frei G, Rosenheimer
GN, Lerrer B, Cohen HY, Nagler A, Fibach E et al (2012) Nicotinamide, a
SIRT1 inhibitor, inhibits differentiation and facilitates expansion of
hematopoietic progenitor cells with enhanced bone marrow homing
and engraftment. Exp Hematol 40:342 – 355.e1
33. Shyh-Chang N, Locasale JW, Lyssiotis CA, Zheng Y, Teo RY, Ratanasirin-
trawoot S, Zhang J, Onder T, Unternaehrer JJ, Zhu H et al (2013) Influ-
ence of threonine metabolism on S-adenosylmethionine and histone
methylation. Science 339: 222 – 226
34. Teslaa T, Teitell MA (2015) Pluripotent stem cell energy metabolism: an
update. EMBO J 34: 138 – 153
35. Shiraki N, Shiraki Y, Tsuyama T, Obata F, Miura M, Nagae G, Aburatani
H, Kume K, Endo F, Kume S (2014) Methionine metabolism regulates
maintenance and differentiation of human pluripotent stem cells. Cell
Metab 19: 780 – 794
36. Hirschey MD, DeBerardinis RJ, Diehl AME, Drew JE, Frezza C, Green MF,
Jones LW, Ko YH, Le A, Lea MA et al (2015) Dysregulated metabolism
contributes to oncogenesis. Semin Cancer Biol 35(Suppl): S129 – S150
37. Bröske A-M, Vockentanz L, Kharazi S, Huska MR, Mancini E, Scheller M,
Kuhl C, Enns A, Prinz M, Jaenisch R et al (2009) DNA methylation
protects hematopoietic stem cell multipotency from myeloerythroid
restriction. Nat Genet 41: 1207 – 1215
38. Sheaffer KL, Kim R, Aoki R, Elliott EN, Schug J, Burger L, Schübeler
D, Kaestner KH (2014) DNA methylation is required for the control
of stem cell differentiation in the small intestine. Genes Dev 28:
652 – 664
39. Sen GL, Reuter JA, Webster DE, Zhu L, Khavari PA (2010) DNMT1 main-
tains progenitor function in self-renewing somatic tissue. Nature 463:
563 – 567
40. Avgustinova A, Benitah SA (2016) Epigenetic control of adult stem cell
function. Nat Rev Mol Cell Biol 17: 643 – 658
41. Tsukada Y-I, Fang J, Erdjument-Bromage H, Warren ME, Borchers CH,
Tempst P, Zhang Y (2006) Histone demethylation by a family of JmjC
domain-containing proteins. Nature 439: 811 – 816
42. Yang H, Lin H, Xu H, Zhang L, Cheng L, Wen B, Shou J, Guan K, Xiong
Y, Ye D (2014) TET-catalyzed 5-methylcytosine hydroxylation is dynam-
ically regulated by metabolites. Cell Res 24: 1017 – 1020
43. Hore TA, von Meyenn F, Ravichandran M, Bachman M, Ficz G, Oxley D,
Santos F, Balasubramanian S, Jurkowski TP, Reik W (2016) Retinol and
ascorbate drive erasure of epigenetic memory and enhance reprogram-
ming to naïve pluripotency by complementary mechanisms. Proc Natl
Acad Sci USA 113: 12202 – 12207
44. D’Aniello C, Habibi E, Cermola F, Paris D, Russo F, Fiorenzano A, Di
Napoli G, Melck DJ, Cobellis G, Angelini C et al (2017) Vitamin C and l-
proline antagonistic effects capture alternative states in the pluripo-
tency continuum. Stem Cell Reports 8: 1 – 10
45. D’Aniello C, Cermola F, Patriarca EJ, Minchiotti G (2017) Vitamin C in
stem cell biology: impact on extracellular matrix homeostasis and
epigenetics. Stem Cells Int 2017: 8936156
46. Blaschke K, Ebata KT, Karimi MM, Zepeda-Martínez JA, Goyal P, Maha-
patra S, Tam A, Laird DJ, Hirst M, Rao A et al (2013) Vitamin C induces
Tet-dependent DNA demethylation and a blastocyst-like state in ES
cells. Nature 500: 222 – 226
47. Agathocleous M, Meacham CE, Burgess RJ, Piskounova E, Zhao Z, Crane
GM, Cowin BL, Bruner E, Murphy MM, Chen W et al (2017) Ascorbate
regulates haematopoietic stem cell function and leukaemogenesis.
Nature 549: 476 – 481
48. He X-B, Kim M, Kim S-Y, Yi S-H, Rhee Y-H, Kim T, Lee E-H, Park C-H,
Dixit S, Harrison FE et al (2015) Vitamin C facilitates dopamine neuron
differentiation in fetal midbrain through TET1- and JMJD3-dependent
epigenetic control manner. Stem Cells 33: 1320 – 1332
49. Wang T, Chen K, Zeng X, Yang J, Wu Y, Shi X, Qin B, Zeng L, Esteban
MA, Pan G et al (2011) The histone demethylases Jhdm1a/1b enhance
somatic cell reprogramming in a vitamin-C-dependent manner. Cell
Stem Cell 9: 575 – 587
50. Forneris F, Binda C, Vanoni MA, Mattevi A, Battaglioli E (2005) Histone
demethylation catalysed by LSD1 is a flavin-dependent oxidative
process. FEBS Lett 579: 2203 – 2207
51. Whyte WA, Bilodeau S, Orlando DA, Hoke HA, Frampton GM, Foster CT,
Cowley SM, Young RA (2012) Enhancer decommissioning by LSD1
during embryonic stem cell differentiation. Nature 482: 221 – 225
52. Eliazer S, Shalaby NA, Buszczak M (2011) Loss of lysine-specific
demethylase 1 nonautonomously causes stem cell tumors in the Droso-
phila ovary. Proc Natl Acad Sci USA 108: 7064 – 7069
53. Eliazer S, Palacios V, Wang Z, Kollipara RK, Kittler R, Buszczak M (2014)
Lsd1 restricts the number of germline stem cells by regulating multiple
targets in escort cells. PLoS Genet 10: e1004200
54. Ryall JG, Dell’Orso S, Derfoul A, Juan A, Zare H, Feng X, Clermont D,
Koulnis M, Gutierrez-Cruz G, Fulco M et al (2015) The NAD+-depen-
dent SIRT1 deacetylase translates a metabolic switch into regulatory
epigenetics in skeletal muscle stem cells. Cell Stem Cell 16:
171 – 183
55. Rodríguez-Colman MJ, Schewe M, Meerlo M, Stigter E, Gerrits J, Pras-
Raves M, Sacchetti A, Hornsveld M, Oost KC, Snippert HJ et al (2017)
Interplay between metabolic identities in the intestinal crypt supports
stem cell function. Nature 543: 424 – 427
56. Yu JSL, Cui W (2016) Proliferation, survival and metabolism: the role of
PI3K/AKT/mTOR signalling in pluripotency and cell fate determination.
Development 143: 3050 – 3060
ª 2017 The Authors EMBO reports
Sumitra Tatapudy et al The cell biology of cell fate decisions EMBO reports
11
57. Bulut-Karslioglu A, Biechele S, Jin H, Macrae TA, Hejna M, Gertsenstein
M, Song JS, Ramalho-Santos M (2016) Inhibition of mTOR induces a
paused pluripotent state. Nature 540: 119 – 123
58. Vannini N, Girotra M, Naveiras O, Nikitin G, Campos V, Giger S, Roch
A, Auwerx J, Lutolf MP (2016) Specification of haematopoietic stem
cell fate via modulation of mitochondrial activity. Nat Commun 7:
13125
59. Flores A, Schell J, Krall AS, Jelinek D, Miranda M, Grigorian M, Braas D,
White AC, Zhou JL, Graham NA et al (2017) Lactate dehydrogenase
activity drives hair follicle stem cell activation. Nat Cell Biol 19:
1017 – 1026
60. Schell JC, Wisidagama DR, Bensard C, Zhao H, Wei P, Tanner J, Flores A,
Mohlman J, Sorensen LK, Earl CS et al (2017) Control of intestinal stem
cell function and proliferation by mitochondrial pyruvate metabolism.
Nat Cell Biol 19: 1027 – 1036
61. Sandoval IT, Delacruz RGC, Miller BN, Hill S, Olson KA, Gabriel AE, Boyd
K, Satterfield C, Remmen HV, Rutter J et al (2017) A metabolic switch
controls intestinal differentiation downstream of Adenomatous polypo-
sis coli (APC). Elife 6: e22706
62. Clevers H, Loh KM, Nusse R (2014) Stem cell signaling. An integral
program for tissue renewal and regeneration: Wnt signaling and stem
cell control. Science 346: 1248012
63. Muncan V, Sansom OJ, Tertoolen L, Phesse TJ, Begthel H, Sancho E, Cole
AM, Gregorieff A, de Alboran IM, Clevers H et al (2006) Rapid loss of
intestinal crypts upon conditional deletion of the Wnt/Tcf-4 target
gene c-Myc. Mol Cell Biol 26: 8418 – 8426
64. Cordero JB, Stefanatos RK, Scopelliti A, Vidal M, Sansom OJ (2012) Indu-
cible progenitor-derived Wingless regulates adult midgut regeneration
in Drosophila. EMBO J 31: 3901 – 3917
65. Nathan C, Cunningham-Bussel A (2013) Beyond oxidative stress: an
immunologist’s guide to reactive oxygen species. Nat Rev Immunol 13:
349 – 361
66. Bigarella CL, Liang R, Ghaffari S (2014) Stem cells and the impact of
ROS signaling. Development 141: 4206 – 4218
67. Kim S-U, Park Y-H, Kim J-M, Sun H-N, Song I-S, Huang SM, Lee S-H,
Chae J-I, Hong S, Sik Choi S et al (2014) Dominant role of peroxire-
doxin/JNK axis in stemness regulation during neurogenesis from
embryonic stem cells. Stem Cells 32: 998 – 1011
68. Hochmuth CE, Biteau B, Bohmann D, Jasper H (2011) Redox regulation
by Keap1 and Nrf2 controls intestinal stem cell proliferation in Droso-
phila. Cell Stem Cell 8: 188 – 199
69. Tan SWS, Lee QY, Wong BSE, Cai Y, Baeg GH (2017) Redox homeostasis
plays important roles in the maintenance of the Drosophila testis
germline stem cells. Stem Cell Reports 9: 342 – 354
70. Tothova Z, Kollipara R, Huntly BJ, Lee BH, Castrillon DH, Cullen DE,
McDowell EP, Lazo-Kallanian S, Williams IR, Sears C et al (2007) FoxOs
are critical mediators of hematopoietic stem cell resistance to physio-
logic oxidative stress. Cell 128: 325 – 339
71. Owusu-Ansah E, Banerjee U (2009) Reactive oxygen species prime
Drosophila haematopoietic progenitors for differentiation. Nature 461:
537 – 541
72. Pervaiz S, Taneja R, Ghaffari S (2009) Oxidative stress regulation of
stem and progenitor cells. Antioxid Redox Signal 11: 2777 – 2789
73. Su B, Mitra S, Gregg H, Flavahan S, Chotani MA, Clark KR, Goldschmidt-
Clermont PJ, Flavahan NA (2001) Redox regulation of vascular smooth
muscle cell differentiation. Circ Res 89: 39 – 46
74. Le Belle JE, Orozco NM, Paucar AA, Saxe JP, Mottahedeh J, Pyle AD, Wu
H, Kornblum HI (2011) Proliferative neural stem cells have high
endogenous ROS levels that regulate self-renewal and neurogenesis in
a PI3K/Akt-dependant manner. Cell Stem Cell 8: 59 – 71
75. Morimoto H, Iwata K, Ogonuki N, Inoue K, Atsuo O, Kanatsu-Shinohara
M, Morimoto T, Yabe-Nishimura C, Shinohara T (2013) ROS are
required for mouse spermatogonial stem cell self-renewal. Cell Stem
Cell 12: 774 – 786
76. Jang Y-Y, Sharkis SJ (2007) A low level of reactive oxygen species selects
for primitive hematopoietic stem cells that may reside in the low-
oxygenic niche. Blood 110: 3056 – 3063
77. Webb BA, Chimenti M, Jacobson MP, Barber DL (2011) Dysregulated
pH: a perfect storm for cancer progression. Nat Rev Cancer 11:
671 – 677
78. White KA, Grillo-Hill BK, Barber DL (2017) Cancer cell behaviors medi-
ated by dysregulated pH dynamics at a glance. J Cell Sci 130:
663 – 669
79. Harguindey S, Reshkin SJ, Orive G, Arranz JL, Anitua E (2007) Growth
and trophic factors, pH and the Na+/H+ exchanger in Alzheimer’s
disease, other neurodegenerative diseases and cancer: new therapeutic
possibilities and potential dangers. Curr Alzheimer Res 4: 53 – 65
80. Wolfe DM, Lee J-H, Kumar A, Lee S, Orenstein SJ, Nixon RA (2013)
Autophagy failure in Alzheimer’s disease and the role of defective lyso-
somal acidification. Eur J Neurosci 37: 1949 – 1961
81. Putney LK, Barber DL (2003) Na-H exchange-dependent increase in
intracellular pH times G2/M entry and transition. J Biol Chem 278:
44645 – 44649
82. Denker SP, Barber DL (2002) Cell migration requires both ion transloca-
tion and cytoskeletal anchoring by the Na-H exchanger NHE1. J Cell
Biol 159: 1087 – 1096
83. Stock C, Schwab A (2009) Protons make tumor cells move like clock-
work. Pflugers Arch 458: 981 – 992
84. Ulmschneider B, Grillo-Hill BK, Benitez M, Azimova DR, Barber DL,
Nystul TG (2016) Increased intracellular pH is necessary for adult
epithelial and embryonic stem cell differentiation. J Cell Biol 215:
345 – 355
85. Singh Y, Zhou Y, Shi X, Zhang S, Umbach AT, Salker MS, Lang KS, Lang
F (2016) Alkaline cytosolic ph and high sodium hydrogen exchanger 1
(NHE1) activity in Th9 cells. J Biol Chem 291: 23662 – 23671
86. Amith SR, Wilkinson JM, Fliegel L (2016) Na+/H+ exchanger NHE1 regu-
lation modulates metastatic potential and epithelial-mesenchymal
transition of triple-negative breast cancer cells. Oncotarget 7:
21091 – 21113
87. Li X, Karki P, Lei L, Wang H, Fliegel L (2009) Na+/H+ exchanger isoform
1 facilitates cardiomyocyte embryonic stem cell differentiation. Am J
Physiol Heart Circ Physiol 296: H159 –H170
88. Edwards LJ, Williams DA, Gardner DK (1998) Intracellular pH of the
mouse preimplantation embryo: amino acids act as buffers of intracel-
lular pH. Hum Reprod 13: 3441 – 3448
89. Wang H, Singh D, Fliegel L (1997) The Na+/H+ antiporter potentiates
growth and retinoic acid-induced differentiation of P19 embryonal
carcinoma cells. J Biol Chem 272: 26545 – 26549
90. Gao W, Zhang H, Chang G, Xie Z, Wang H, Ma L, Han Z, Li Q, Pang T
(2014) Decreased intracellular pH induced by cariporide differentially
contributes to human umbilical cord-derived mesenchymal stem cells
differentiation. Cell Physiol Biochem 33: 185 – 194
91. Krüger J, Bohrmann J (2015) Bioelectric patterning during oogenesis:
stage-specific distribution of membrane potentials, intracellular pH
and ion-transport mechanisms in Drosophila ovarian follicles. BMC Dev
Biol 15: 1
EMBO reports ª 2017 The Authors
EMBO reports The cell biology of cell fate decisions Sumitra Tatapudy et al
12
92. Salker MS, Zhou Y, Singh Y, Brosens J, Lang F (2015) LeftyA sensitive
cytosolic pH regulation and glycolytic flux in Ishikawa human endome-
trial cancer cells. Biochem Biophys Res Commun 460: 845 – 849
93. Grillo-Hill BK, Choi C, Jimenez-Vidal M, Barber DL (2015) Increased H+
efflux is sufficient to induce dysplasia and necessary for viability with
oncogene expression. Elife 4: e03270
94. Uzman JA, Patil S, Uzgare AR, Sater AK (1998) The role of intracellular
alkalinization in the establishment of anterior neural fate in Xenopus.
Dev Biol 193: 10 – 20
95. Wu J, Glimcher LH, Aliprantis AO (2008) HCO3-/Cl- anion exchanger
SLC4A2 is required for proper osteoclast differentiation and function.
Proc Natl Acad Sci US A 105: 16934 – 16939
96. Oginuma M, Moncuquet P, Xiong F, Karoly E, Chal J, Guevorkian K,
Pourquié O (2017) A gradient of glycolytic activity coordinates FGF and
Wnt signaling during elongation of the body axis in amniote embryos.
Dev Cell 40: 342 – 353.e10
97. Kottmann RM, Trawick E, Judge JL, Wahl LA, Epa AP, Owens KM,
Thatcher TH, Phipps RP, Sime PJ (2015) Pharmacologic inhibition of
lactate production prevents myofibroblast differentiation. Am J Physiol
Lung Cell Mol Physiol 309: L1305 – L1312
98. Zhu H, Guo S, Zhang Y, Yin J, Yin W, Tao S, Wang Y, Zhang C (2016)
Proton-sensing GPCR-YAP signalling promotes cancer-associated
fibroblast activation of mesenchymal stem cells. Int J Biol Sci 12:
389 – 396
99. Hjelmeland AB, Wu Q, Heddleston JM, Choudhary GS, MacSwords J,
Lathia JD, McLendon R, Lindner D, Sloan A, Rich JN (2011) Acidic
stress promotes a glioma stem cell phenotype. Cell Death Differ 18:
829 – 840
100. Schönichen A, Webb BA, Jacobson MP, Barber DL (2013) Considering
protonation as a posttranslational modification regulating protein
structure and function. Annu Rev Biophys 42: 289 – 314
101. Simons M, Gault WJ, Gotthardt D, Rohatgi R, Klein TJ, Shao Y, Lee H-
J, Wu A-L, Fang Y, Satlin LM et al (2009) Electrochemical cues regu-
late assembly of the Frizzled/Dishevelled complex at the plasma
membrane during planar epithelial polarization. Nat Cell Biol 11:
286 – 294
102. McBrian MA, Behbahan IS, Ferrari R, Su T, Huang T-W, Li K, Hong CS,
Christofk HR, Vogelauer M, Seligson DB et al (2013) Histone acetylation
regulates intracellular pH. Mol Cell 49: 310 – 321
103. Iglesias-Bartolome R, Callejas-Valera JL, Gutkind JS (2013) Control of
the epithelial stem cell epigenome: the shaping of epithelial stem cell
identity. Curr Opin Cell Biol 25: 162 – 169
104. Sperber H, Mathieu J, Wang Y, Ferreccio A, Hesson J, Xu Z, Fischer KA,
Devi A, Detraux D, Gu H et al (2015) The metabolome regulates the
epigenetic landscape during naive-to-primed human embryonic stem
cell transition. Nat Cell Biol 17: 1523 – 1535
105. Nadtochiy SM, Schafer X, Fu D, Nehrke K, Munger J, Brookes PS (2016)
Acidic pH is a metabolic switch for 2-hydroxyglutarate generation and
signaling. J Biol Chem 291: 20188 – 20197
106. Intlekofer AM, Wang B, Liu H, Shah H, Carmona-Fontaine C, Rusten-
burg AS, Salah S, Gunner MR, Chodera JD, Cross JR et al (2017) L-2-
Hydroxyglutarate production arises from noncanonical enzyme func-
tion at acidic pH. Nat Chem Biol 13: 494 – 500
107. Engler AJ, Sen S, Sweeney HL, Discher DE (2006) Matrix elasticity
directs stem cell lineage specification. Cell 126: 677 – 689
108. McBeath R, Pirone DM, Nelson CM, Bhadriraju K, Chen CS (2004) Cell
shape, cytoskeletal tension, and RhoA regulate stem cell lineage
commitment. Dev Cell 6: 483 – 495
109. Hayashi Y, Furue MK, Okamoto T, Ohnuma K, Myoishi Y, Fukuhara Y,
Abe T, Sato JD, Hata R-I, Asashima M (2007) Integrins regulate mouse
embryonic stem cell self-renewal. Stem Cells 25: 3005 – 3015
110. Uda Y, Poh Y-C, Chowdhury F, Wu DC, Tanaka TS, Sato M, Wang N
(2011) Force via integrins but not E-cadherin decreases Oct3/4 expres-
sion in embryonic stem cells. Biochem Biophys Res Commun 415:
396 – 400
111. Song X, Zhu C-H, Doan C, Xie T (2002) Germline stem cells anchored
by adherens junctions in the Drosophila ovary niches. Science 296:
1855 – 1857
112. Song X, Xie T (2002) DE-cadherin-mediated cell adhesion is essential
for maintaining somatic stem cells in the Drosophila ovary. Proc Natl
Acad Sci USA 99: 14813 – 14818
113. O’Reilly AM, Lee H-H, Simon MA (2008) Integrins control the position-
ing and proliferation of follicle stem cells in the Drosophila ovary. J Cell
Biol 182: 801 – 815
114. Tanentzapf G, Devenport D, Godt D, Brown NH (2007) Integrin-depen-
dent anchoring of a stem-cell niche. Nat Cell Biol 9: 1413 – 1418
115. Voog J, D’Alterio C, Jones DL (2008) Multipotent somatic stem cells
contribute to the stem cell niche in the Drosophila testis. Nature 454:
1132 – 1136
116. Issigonis M, Tulina N, de Cuevas M, Brawley C, Sandler L, Matunis E
(2009) JAK-STAT signal inhibition regulates competition in the Droso-
phila testis stem cell niche. Science 326: 153 – 156
117. Liang J, Balachandra S, Ngo S, O’Brien LE (2017) Feedback regulation of
steady-state epithelial turnover and organ size. Nature 548: 588 – 591
118. Brizzi MF, Tarone G, Defilippi P (2012) Extracellular matrix, integrins,
and growth factors as tailors of the stem cell niche. Curr Opin Cell Biol
24: 645 – 651
119. Dalby MJ, Gadegaard N, Oreffo ROC (2014) Harnessing nanotopography
and integrin-matrix interactions to influence stem cell fate. Nat Mater
13: 558 – 569
120. Raymond K, Deugnier M-A, Faraldo MM, Glukhova MA (2009) Adhesion
within the stem cell niches. Curr Opin Cell Biol 21: 623 – 629
121. Xi R (2009) Anchoring stem cells in the niche by cell adhesion mole-
cules. Cell Adh Migr 3: 396 – 401
122. Chen S, Lewallen M, Xie T (2013) Adhesion in the stem cell niche:
biological roles and regulation. Development 140: 255 – 265
123. Larue L, Ohsugi M, Hirchenhain J, Kemler R (1994) E-cadherin null
mutant embryos fail to form a trophectoderm epithelium. Proc Natl
Acad Sci USA 91: 8263 – 8267
124. Stephenson RO, Yamanaka Y, Rossant J (2010) Disorganized epithelial
polarity and excess trophectoderm cell fate in preimplantation
embryos lacking E-cadherin. Development 137: 3383 – 3391
125. Zoldan J, Karagiannis ED, Lee CY, Anderson DG, Langer R, Levenberg S
(2011) The influence of scaffold elasticity on germ layer specification of
human embryonic stem cells. Biomaterials 32: 9612 – 9621
126. Kan NG, Stemmler MP, Junghans D, Kanzler B, de Vries WN, Dominis
M, Kemler R (2007) Gene replacement reveals a specific role for E-
cadherin in the formation of a functional trophectoderm. Development
134: 31 – 41
127. Spencer HL, Eastham AM, Merry CLR, Southgate TD, Perez-Campo F,
Soncin F, Ritson S, Kemler R, Stern PL, Ward CM (2007) E-cadherin
inhibits cell surface localization of the pro-migratory 5T4 oncofetal
antigen in mouse embryonic stem cells. Mol Biol Cell 18: 2838 – 2851
128. Chen T, Yuan D, Wei B, Jiang J, Kang J, Ling K, Gu Y, Li J, Xiao L, Pei G
(2010) E-cadherin-mediated cell-cell contact is critical for induced
pluripotent stem cell generation. Stem Cells 28: 1315 – 1325
ª 2017 The Authors EMBO reports
Sumitra Tatapudy et al The cell biology of cell fate decisions EMBO reports
13
129. Bedzhov I, Alotaibi H, Basilicata MF, Ahlborn K, Liszewska E, Brabletz T,
Stemmler MP (2013) Adhesion, but not a specific cadherin code, is
indispensable for ES cell and induced pluripotency. Stem Cell Res 11:
1250 – 1263
130. Soncin F, Mohamet L, Ritson S, Hawkins K, Bobola N, Zeef L, Merry
CLR, Ward CM (2011) E-cadherin acts as a regulator of transcripts
associated with a wide range of cellular processes in mouse embryonic
stem cells. PLoS One 6: e21463
131. Pieters T, van Roy F (2014) Role of cell-cell adhesion complexes in
embryonic stem cell biology. J Cell Sci 127: 2603 – 2613
132. Mohamet L, Hawkins K, Ward CM (2011) Loss of function of e-cadherin
in embryonic stem cells and the relevance to models of tumorigenesis.
J Oncol 2011: 352616
133. Soncin F, Ward CM (2011) The function of e-cadherin in stem cell
pluripotency and self-renewal. Genes 2: 229 – 259
134. Ying Q-L, Smith A (2017) The art of capturing pluripotency: creating
the right culture. Stem Cell Reports 8: 1457 – 1464
135. Kretzschmar K, Clevers H (2017) Wnt/b-catenin signaling in adult
mammalian epithelial stem cells. Dev Biol 428: 273 – 282
136. Wray J, Kalkan T, Gomez-Lopez S, Eckardt D, Cook A, Kemler R, Smith A
(2011) Inhibition of glycogen synthase kinase-3 alleviates Tcf3 repres-
sion of the pluripotency network and increases embryonic stem cell
resistance to differentiation. Nat Cell Biol 13: 838 – 845
137. Faunes F, Hayward P, Descalzo SM, Chatterjee SS, Balayo T, Trott J,
Christoforou A, Ferrer-Vaquer A, Hadjantonakis A-K, Dasgupta R et al
(2013) A membrane-associated b-catenin/Oct4 complex correlates with
ground-state pluripotency in mouse embryonic stem cells. Development
140: 1171 – 1183
138. Lyashenko N, Winter M, Migliorini D, Biechele T, Moon RT, Hartmann C
(2011) Differential requirement for the dual functions of b-catenin in
embryonic stem cell self-renewal and germ layer formation. Nat Cell
Biol 13: 753 – 761
139. Mahendram S, Kelly KF, Paez-Parent S, Mahmood S, Polena E, Cooney
AJ, Doble BW (2013) Ectopic c-catenin expression partially mimics the
effects of stabilized b-catenin on embryonic stem cell differentiation.
PLoS One 8: e65320
140. Morin-Kensicki EM, Boone BN, Howell M, Stonebraker JR, Teed J,
Alb JG, Magnuson TR, O’Neal W, Milgram SL (2006) Defects in yolk
sac vasculogenesis, chorioallantoic fusion, and embryonic axis elon-
gation in mice with targeted disruption of Yap65. Mol Cell Biol 26:
77 – 87
141. Halder G, Dupont S, Piccolo S (2012) Transduction of mechanical and
cytoskeletal cues by YAP and TAZ. Nat Rev Mol Cell Biol 13: 591 – 600
142. Dupont S, Morsut L, Aragona M, Enzo E, Giulitti S, Cordenonsi M,
Zanconato F, Le Digabel J, Forcato M, Bicciato S et al (2011) Role of
YAP/TAZ in mechanotransduction. Nature 474: 179 – 183
143. Ramalho-Santos M, Yoon S, Matsuzaki Y, Mulligan RC, Melton DA
(2002) ‘Stemness’: transcriptional profiling of embryonic and adult
stem cells. Science 298: 597 – 600
144. Shaw RL, Kohlmaier A, Polesello C, Veelken C, Edgar BA, Tapon N
(2010) The Hippo pathway regulates intestinal stem cell proliferation
during Drosophila adult midgut regeneration. Development 137:
4147 – 4158
145. Staley BK, Irvine KD (2010) Warts and Yorkie mediate intestinal regen-
eration by influencing stem cell proliferation. Curr Biol 20: 1580 – 1587
146. Huang J, Kalderon D (2014) Coupling of Hedgehog and Hippo path-
ways promotes stem cell maintenance by stimulating proliferation. J
Cell Biol 205: 325 – 338
147. McGee KM, Vartiainen MK, Khaw PT, Treisman R, Bailly M (2011)
Nuclear transport of the serum response factor coactivator MRTF-A is
downregulated at tensional homeostasis. EMBO Rep 12: 963 – 970
148. Miralles F, Posern G, Zaromytidou A-I, Treisman R (2003) Actin dynamics
control SRF activity by regulation of its coactivator MAL. Cell 113: 329 – 342
149. Olson EN, Nordheim A (2010) Linking actin dynamics and gene transcrip-
tion to drive cellular motile functions. Nat Rev Mol Cell Biol 11: 353 – 365
150. Wang D-Z, Li S, Hockemeyer D, Sutherland L, Wang Z, Schratt G,
Richardson JA, Nordheim A, Olson EN (2002) Potentiation of serum
response factor activity by a family of myocardin-related transcription
factors. Proc Natl Acad Sci USA 99: 14855 – 14860
151. Parmacek MS (2007) Myocardin-related transcription factors: critical
coactivators regulating cardiovascular development and adaptation.
Circ Res 100: 633 – 644
152. Nobusue H, Onishi N, Shimizu T, Sugihara E, Oki Y, Sumikawa Y, Chiyoda T,
Akashi K, Saya H, Kano K (2014) Regulation of MKL1 via actin cytoskeleton
dynamics drives adipocyte differentiation. Nat Commun 5: 3368
153. McDonald ME, Li C, Bian H, Smith BD, Layne MD, Farmer SR (2015)
Myocardin-related transcription factor A regulates conversion of
progenitors to beige adipocytes. Cell 160: 105 – 118
154. Bian H, Lin JZ, Li C, Farmer SR (2016) Myocardin-related transcription
factor A (MRTFA) regulates the fate of bone marrow mesenchymal stem
cells and its absence in mice leads to osteopenia. Mol Metab 5: 970 – 979
155. Gilbert PM, Havenstrite KL, Magnusson KEG, Sacco A, Leonardi NA, Kraft
P, Nguyen NK, Thrun S, Lutolf MP, Blau HM (2010) Substrate elasticity
regulates skeletal muscle stem cell self-renewal in culture. Science 329:
1078 – 1081
156. Myers FB, Silver JS, Zhuge Y, Beygui RE, Zarins CK, Lee LP, Abilez OJ
(2013) Robust pluripotent stem cell expansion and cardiomyocyte dif-
ferentiation via geometric patterning. Integr Biol 5: 1495 – 1506
157. Muliyil S, Narasimha M (2014) Mitochondrial ROS regulates cytoskele-
tal and mitochondrial remodeling to tune cell and tissue dynamics in
a model for wound healing. Dev Cell 28: 239 – 252
158. Irvine KD, Harvey KF (2015) Control of organ growth by patterning and
hippo signaling in Drosophila. Cold Spring Harb Perspect Biol 7:
a019224
159. Jansen M, ten Klooster JP, Offerhaus GJ, Clevers H (2009) LKB1 and
AMPK family signaling: the intimate link between cell polarity and
energy metabolism. Physiol Rev 89: 777 – 798
160. Lee JH, Koh H, Kim M, Kim Y, Lee SY, Karess RE, Lee S-H, Shong M, Kim
J-M, Kim J et al (2007) Energy-dependent regulation of cell structure
by AMP-activated protein kinase. Nature 447: 1017 – 1020
161. Mirouse V, Swick LL, Kazgan N, St Johnston D, Brenman JE (2007) LKB1
and AMPK maintain epithelial cell polarity under energetic stress. J Cell
Biol 177: 387 – 392
162. Trivedi B, Danforth WH (1966) Effect of pH on the kinetics of frog
muscle phosphofructokinase. J Biol Chem 241: 4110 – 4112
163. Erecinska M, Deas J, Silver IA (1995) The effect of pH on glycolysis and
phosphofructokinase activity in cultured cells and synaptosomes. J
Neurochem 65: 2765 – 2772
164. Srivastava J, Barreiro G, Groscurth S, Gingras AR, Goult BT, Critchley DR,
Kelly MJS, Jacobson MP, Barber DL (2008) Structural model and func-
tional significance of pH-dependent talin-actin binding for focal adhe-
sion remodeling. Proc Natl Acad Sci USA 105: 14436 – 14441
165. Frantz C, Barreiro G, Dominguez L, Chen X, Eddy R, Condeelis J, Kelly
MJS, Jacobson MP, Barber DL (2008) Cofilin is a pH sensor for actin free
barbed end formation: role of phosphoinositide binding. J Cell Biol 183:
865 – 879
EMBO reports ª 2017 The Authors
EMBO reports The cell biology of cell fate decisions Sumitra Tatapudy et al
14
